perfused rat pancreas
Recently Published Documents


TOTAL DOCUMENTS

372
(FIVE YEARS 0)

H-INDEX

38
(FIVE YEARS 0)

2019 ◽  
Author(s):  
Ida M. Modvig ◽  
Daniel B. Andersen ◽  
Kaare V. Grunddal ◽  
Rune E. Kuhre ◽  
Christoffer Martinussen ◽  
...  

AbstractObjectiveGastrointestinal hormones contribute to the beneficial effects of Roux-en-Y gastric bypass surgery (RYGB) on glycemic control. Secretin is secreted from duodenal S-cells in response to low luminal pH, but it is unknown whether its secretion is altered after RYGB and if secretin contributes to the post-operative improvement in glycemic control. We hypothesized that secretin secretion increases after RYGB as a result of the diversion of nutrients to more distal parts of the small intestine, and thereby affects islet hormone release.MethodsA specific secretin radioimmunoassay was developed, evaluated biochemically, and used to quantify plasma concentrations of secretin in 13 obese individuals before, 1 week after and 3 months after RYGB. Distribution of secretin and its receptor was assessed by RNA-sequencing, mass-spectrometry and in situ hybridization in human and rat tissues. Isolated, perfused rat intestine and pancreas were used to explore the molecular mechanism underlying glucose-induced secretin secretion and to study direct effects of secretin on glucagon, insulin and somatostatin secretion. Secretin was administered alone or in combination with GLP-1 to non-sedated rats to evaluate effects on glucose regulation.ResultsPlasma postprandial secretin was more than doubled in humans after RYGB (P<0.001). The distal small intestine harbored secretin expressing cells in both rats and humans. Glucose increased secretion of secretin in a sodium-glucose co-transporter dependent manner when administered to the distal part but not into the proximal part of the rat small intestine. Secretin stimulated somatostatin secretion (fold change: 1.59, P<0.05) from the perfused rat pancreas but affected neither insulin (P=0.2) nor glucagon (P=0.97) secretion. When administered to rats in vivo, insulin secretion was attenuated and glucagon secretion increased (P=0.04), while blood glucose peak time was delayed (from 15 min to 45 min) and gastric emptying time prolonged (P=0.004).ConclusionGlucose-sensing secretin cells located in the distal part of the small intestine may contribute to increased plasma concentrations observed after RYGB. The metabolic role of the distal S-cells warrants further studies.





2014 ◽  
Vol 306 (6) ◽  
pp. E627-E634 ◽  
Author(s):  
Michela Riz ◽  
Morten Gram Pedersen ◽  
Gianna Maria Toffolo ◽  
Guido Haschke ◽  
Hans-Christoph Schneider ◽  
...  

The experimental protocol of the perfused rat pancreas is commonly used to evaluate β-cell function. In this context, mathematical models become useful tools through the determination of indexes that allow the assessment of β-cell function in different experimental groups and the quantification of the effects of antidiabetic drugs, secretagogues, or treatments. However, a minimal model applicable to the isolated perfused rat pancreas has so far been unavailable. In this work, we adapt the C-peptide minimal model applied previously to the intravenous glucose tolerance test to obtain a specific model for the experimental settings of the perfused pancreas. Using the model, it is possible to estimate indexes describing β-cell responsivity for first (ΦD) and second phase (ΦS, T) of insulin secretion. The model was initially applied to untreated pancreata and afterward used for the assessment of pharmacologically relevant agents (the gut hormone GLP-1, the potent GLP-1 receptor agonist lixisenatide, and a GPR40/FFAR1 agonist, SAR1) to quantify and differentiate their effect on insulin secretion. Model fit was satisfactory, and parameters were estimated with good precision for both untreated and treated pancreata. Model application showed that lixisenatide reaches improvement of β-cell function similarly to GLP-1 (11.7- vs. 13.1-fold increase in ΦD and 2.3- vs. 2.8-fold increase in ΦS) and demonstrated that SAR1 leads to an additional improvement of β-cell function in the presence of postprandial GLP-1 levels.



2013 ◽  
Vol 29 (1) ◽  
pp. 19 ◽  
Author(s):  
Zheng-er Jiang ◽  
ChengZhe Jiang ◽  
Baihui Chen ◽  
Chin Su Koh ◽  
Jun-Hwan Yong ◽  
...  


2011 ◽  
Vol 55 (6) ◽  
pp. 3008-3011 ◽  
Author(s):  
Kent J. Fanning ◽  
Thomas A. Robertson ◽  
Johannes B. Prins ◽  
Michael S. Roberts

ABSTRACTThis work sought to define how pancreatitis affected antibiotic distribution in a perfused rat pancreas model. The distribution kinetics of four antibiotics were examined in control animals and animals with pancreatitis. Meropenem and piperacillin distributed into the extracellular space, and their distribution kinetics were unaffected by pancreatitis. In contrast, in pancreatic cells from animals with pancreatitis, ciprofloxacin showed a reduced uptake and clindamycin showed a reduced distribution.





2009 ◽  
Vol 91 (03) ◽  
pp. 282-286
Author(s):  
T. Ikeda ◽  
T. Hoshino ◽  
M. Honda ◽  
T. Takeuchi ◽  
Y. Ito ◽  
...  


2009 ◽  
Vol 153 (1-3) ◽  
pp. 37-42 ◽  
Author(s):  
Ramona A. Silvestre ◽  
Eva M. Egido ◽  
Raquel Hernández ◽  
José Marco


2009 ◽  
Vol 152 (1-3) ◽  
pp. 61-66 ◽  
Author(s):  
Eva M. Egido ◽  
Raquel Hernández ◽  
José Marco ◽  
Ramona A. Silvestre


Sign in / Sign up

Export Citation Format

Share Document